“Stefan is a seasoned executive with an extensive background in organizational development, business development, and marketing & sales management in industryleading medical device companies” said Christoph Lengauer, CEO of GALS. “We are confident that Stefan’s experience and broad skill set will play an important role in executing GALS’ program initiatives in Germany and anchor GALS deeper with all stakeholders focusing to propel medical innovation into successful companies”.
Prior to joining GALS, Stefan Beerhalter held a variety of senior roles in the medical device industry, most recently as Vice President Global Sales & Marketing for CARDIONOVUM GmbH, Germany and Managing Director for OrbusNeich Medical, Germany. He holds a degree in Biomedical Engineering from the University of Applied Sciences, Hamburg, Germany and a degree in Industrial Engineering and Management from the University of Applied Sciences, Kiel, Germany.
Stefan Beerhalter will identify and manage the GALS relationships with key stakeholders within the German landscape. “My role presents a unique opportunity to help young German companies scale further through the GALS program and make therapies and devices developed in Germany available to improve the treatment of patients in the U.S. and beyond” said Stefan Beerhalter.
About the German Accelerator Life Sciences
The German Accelerator Life Sciences (GALS) helps German startups and young companies succeed in the global marketplace. GALS is centrally located and highly connected in the world’s leading life sciences innovation hub in Cambridge, Massachusetts, and offers support in multiple areas: from operational assistance and high end mentoring to strategic guidance by experienced industry experts and key opinion leaders. GALS launched in 2015 and is supported by the German Federal Ministry for Economic Affairs and Energy (BMWi).
German Accelerator Life Sciences
Annika Pierson, COO